DE RUEHMO #5148/01 2981212
ZNR UUUUU ZZH
P 251212Z OCT 07
FM AMEMBASSY MOSCOW
TO RUCPDOC/USDOC WASHDC PRIORITY
INFO RUEHC/SECSTATE WASHDC 4835
RHMFIUU/US CUSTOMS AND BORDER PROTECTION WASHINGTON DC
UNCLAS MOSCOW 005148
USDOC FOR 532/OEA/MHAMES/LRITTER
USDOC FOR 3150/USFCS/OIO/CEENIS/MCOSTA
E.O. 12958: N/A
TAGS: BEXP ETRD ETTC RS
SUBJECT: EXTRANCHECK: PRE-LICENSE CHECK: SRI
BIOMEDICINSKOY KHIMII IM. V.N. OREKHOVICHA RAMN,
MOSCOW, RUSSIA, LICENSE NO. D382923
REFTEL: USDOC 08772
1. Unauthorized disclosure of the information provided
below is prohibited by Section 12C of the Export
2. Reftel requested a Pre-license check to determine
the legitimacy and reliability of the end-user, SRI
Biomedicinskoy Khimii im. V.N.Orekhovicha, Moscow,
Russia. The company is listed on BIS license
application D382923 as the ultimate consignee of an
acrylic glove box chamber with airlock door. These
items are controlled for chemical or biological
warfare, anti-terrorism reasons under ECCN 2B352. The
licensee is Plas-Labs Inc., 401 E. North st., Lansing,
3. On October 19, 2007, Export Control Attache Peter
Liston, Export Control Attache Donald Pearce, and FSN
Natalya Shipitsina conducted the requested pre-license
check at the offices of SRI Biomedicinskoy Khimii im.
V.N.Orekhovicha, 10, Pogodinskaya st., Moscow, Russia.
The export control team met with Alexander I.
Archakov, Director, Full member of RAMS, Prof.
4. Institute of Biomedical Chemistry RAMS is a
structural subdivision of Russian Academy of Medical
Sciences. Staff consists of more than 200 research
associates, including 2 Full Members of RAMS, 7
Professors, 72 Candidates and 30 Doctors of Science.
There are 3 departments and 8 research laboratories at
The basic research and development activity of the
Institute is carried out in accordance with research
priority directions approved by Medico-Biological
Sciences Committee of RAMS. They are:
- study of genetic, molecular, biochemical,
physiological and morphological principals of vital
activity to prevent diseases and renew unsound
- study of pharmacological regulation in normal and
pathology. New drug design and computer modeling.
Institute of Biomedical Chemistry RAMS is one of the
leading subdivisions of RAMS on fundamental directions
of present-day biomedical science such as
bioinformatics, proteomics, nanotechnologies.
The most significant scientific and practical
achievements of the Institute are: development of
hepatoprotector "Phosphogliv", revealing of
oncomarkers at the initial stage of oncological
diseases, creation of express-diagnosis method of
acute viral hepatitis, creation of vaccine prototype
against hepatitis C.
The Institute is large complex with multi-layered
security. It is located within a fenced-in compound,
with 24 hour manned security.
The export control team was given a tour of the
facility and the lab area where the acrylic glove box
chamber with airlock door will be located. The lab
where the glove box will be located is a single entry
lab room with a dead-bolt locking system that only 4
staff members have keys and access. The building
where the glove box will be housed appears to be in
the process of a security upgrade, with electronic
card-key access system being recently installed on
some lab doors.
5. ECO NOTE: During the PLC at SRI Biomedicinskoy
Khimii im., the ECO team discovered that Alexander I.
Archakov, the point of contact for the glove box, had
been declared permanently ineligible to visit the
United States by the U.S. Consulate in Moscow on or
about March 2007 under section 212(a)(3)(A)(ii) of the
Immigration and Naturalization Act, which prohibits
issuance of a visa to any alien who seeks to enter the
United States to engage in any unlawful activity.
On October 22, 2007, Export Control Attache Liston
confirmed with the U.S. Consulate in Moscow that
Alexander I. Archekov had been denied a tourist visa
on his last three (3) attempts to obtain one.
6. Recommendations: Post recommends against issuing
this license at this time to SRI Biomedicinskoy Khimii
im. V.N.Orekhovicha, Moscow, Russia, as reliable
recipients of sensitive U.S. origin commodities for
the reason stated above. Post suggests that HQ
explores with State the reason Alexander I Archekov
has been declared permanently ineligible to receive a
U.S. visa. It is requested that post be notified of
final disposition of the application, and of any
shipments for this organization in order to conduct
appropriate FCS follow-up and statistical reporting.